{
    "clinical_study": {
        "@rank": "58895", 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine if hyperactivity accompanies abrupt opiate\n      withdrawal in heroin addicts, to determine if computerized solid state activity monitors are\n      capable of quantifying hyperactivity, and to quantify the physical and affective symptoms\n      occurring during abrupt withdrawal in heroin addicts and morphine's capacity to alleviate\n      these symptoms."
        }, 
        "brief_title": "Activity Monitoring Assessment of Opiate Withdrawal - 4", 
        "condition": "Opioid-Related Disorders", 
        "condition_browse": {
            "mesh_term": "Opioid-Related Disorders"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Please contact site for information."
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "55 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": "0", 
        "firstreceived_date": "September 20, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00000335", 
            "org_study_id": "NIDA-3-0009-4", 
            "secondary_id": "Y01-3-0009-4"
        }, 
        "intervention": {
            "intervention_name": "Morphine", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Morphine"
        }, 
        "lastchanged_date": "March 20, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Washington", 
                    "country": "United States", 
                    "state": "District of Columbia", 
                    "zip": "20422"
                }, 
                "name": "Washington DC VA"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Activity Monitoring Assessment of Opiate Withdrawal", 
        "overall_official": {
            "affiliation": "Washington DC VA", 
            "last_name": "Steven Deutsch, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 2", 
        "primary_outcome": [
            {
                "measure": "Depression"
            }, 
            {
                "measure": "Anxiety"
            }, 
            {
                "measure": "Withdrawal severity"
            }, 
            {
                "measure": "Activity"
            }, 
            {
                "measure": "Opiate secondary withdrawal"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00000335"
        }, 
        "source": "National Institute on Drug Abuse (NIDA)", 
        "sponsors": {
            "collaborator": {
                "agency": "Washington DC VA", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "National Institute on Drug Abuse (NIDA)", 
                "agency_class": "NIH"
            }
        }, 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2002"
    }, 
    "geocoordinates": {
        "Washington DC VA": "38.895 -77.036"
    }
}